Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Indices fluctuate due to price swings in components and shifting sentiment. This short intro outlines the main causes of index volatility.
22,408 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
AI-driven demand and easing supply bottlenecks push chipmakers into the spotlight. Here’s a timely look at the best s...
Choosing between VNQ and RWX boils down to cost, geography, and how you want to shape your real estate exposure. This...
Boeing, Honeywell, and 3M all fell in after-hours trading as Q4 results rolled out, signaling divergent paths. This p...
Analysts issued fresh price targets on nine stocks, signaling divergent views as U.S. markets contend with rate uncer...
Qualcomm is betting big on non-phone AI devices, teaming with top AI firms to power wearables that act as autonomous ...
3D Systems' Q1 2026 update sheds light on demand, margins, and cash flow across its printing systems, materials, and ...
PepsiCo beat expectations in Q1 with revenue rising 8.5% and earnings surpassing estimates. International momentum an...
IBM led a narrow rally in a mixed tech session, jumping 8% while Oracle, Cisco, and HPE drifted. The move raises ques...
Midweek market noise is loud. This Wednesday reads roundup cuts through the chatter with 10 practical investing stori...
Oil prices rise as traders weigh demand and supply, while U.S. stock futures slip, hinting at caution as Wall Street ...
Anthropic is moving toward a public listing, with Amazon and Google as key backers. If the IPO hits a trillion-dollar...